Metraipolis › archive › dc_d717d4e2ad9d

The metabolic escape: how tumor metabolic reprogramming drives drug resistance — Europe PMC PMID:42291443

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42291443
DOI
10.7717/peerj.21400
License (as archived)
solo-consultazione
Archived
2026-10-31T17:08:53.065Z
SHA-256 of the archived text
dab1854689e07083e3e9f48ef24355d05a7b053b624e1926986168d774d00947
Stable URL of this page
https://metraipolis.com/documento/dc_d717d4e2ad9d

How to cite

The metabolic escape: how tumor metabolic reprogramming drives drug resistance — Europe PMC PMID:42291443 — Europe PMC (en), https://europepmc.org/article/MED/42291443 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d717d4e2ad9d (Metraipolis archive dc_d717d4e2ad9d, sha256 dab1854689e07083e3e9f48ef24355d05a7b053b624e1926986168d774d00947)
BibTeX
@misc{dcd717d4e2ad9d,
  title = {The metabolic escape: how tumor metabolic reprogramming drives drug resistance — Europe PMC PMID:42291443},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42291443},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d717d4e2ad9d; sha256 dab1854689e07083e3e9f48ef24355d05a7b053b624e1926986168d774d00947},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42291443. Agents can read the archived copy with the MCP tool read_document.